13
What’s in a name – biosimilars? Kevin Grant Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group, TGA ARCS Scientific Congress 2014 10 September 2014

What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

Page 1: What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,

What’s in a name – biosimilars?

Kevin Grant Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group, TGA ARCS Scientific Congress 2014

10 September 2014

Page 2: What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,

What is a biosimilar? A biosimilar is a “copy” version of an approved biological medicine with demonstrated similarity in physicochemical, biological and immunological characteristics, efficacy and safety, based on a comprehensive comparability study. Biosimilars are variously termed: • Similar Biotherapeutic Products (WHO) • Similar Biological Medicinal Products (EU/TGA) • “biological products shown to be biosimilar to, or interchangeable with, an FDA-licensed biological reference

product” (US FDA) • follow-on biologics (PMDA, Japan) and • subsequent entry biologics (Health Canada).

1 What’s in a name – biosimilars?

Page 3: What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,

2

Biosimilar ≠ generic

What’s in a name – biosimilars?

Page 4: What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,

1.Size

3 What’s in a name – biosimilars?

Asprin vs IgG From: Kozlowski et al NEJM 2011;365:385-388

Page 5: What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,

1. Size 2. Complexity – 4 levels of structure

Biosimilar

What’s in a name – biosimilars? 4

Page 6: What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,

1. Size 2. Complexity - glycosylation

5 What’s in a name – biosimilars?

Page 7: What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,

6

Variability – e.g. EPO

• Mass = 27948±285 deglycosylated 18240±4

• 2 disulphide bonds • 3 N-glycosylation • 2 O-glycosylation sites • Many types of glycans • C-terminal truncation

Even the most controlled biotechnological process produces a spectrum of 100 000s of molecules – all having different activity, half-life and potential to induce an immune reaction.

What’s in a name – biosimilars?

Page 8: What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,

1. Size 2. Complexity 3. Variability

Biosimilar ≠ generic Comparable ≠ bioequivalent

7 What’s in a name – biosimilars?

Page 9: What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,

Naming safety • Information • Warning • Clarity

8 What’s in a name – biosimilars?

Page 10: What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,

Naming safety For biosimilars: • Identify reference product • Distinguish from other biosimilars • Clarify use

9 What’s in a name – biosimilars?

Page 11: What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,

Naming safety TGA biosimilar naming policy: • ABN of reference product • Biosimilar identifier based on INN • Linked to advice in PI

10 What’s in a name – biosimilars?

Page 12: What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,

Thank you!

11 What’s in a name – biosimilars?

Page 13: What’s in a name – biosimilars? · What’s in a name – biosimilars? Kevin Grant . Section Head, Office of Laboratories & Scientific Services, Monitoring & Compliance Group,